Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if combining the drugs thymoglobulin,
methylprednisolone, cyclosporine, and G-CSF (NeupogenTM or NeulastaTM ) can help to control
severe aplastic anemia (AA) or hypoplastic myelodysplastic syndrome (MDS). The safety of this
combination therapy will also be studied.